Increased expression of hepcidin has been thought to indicate unfavorable outcomes for patients with various malignancies including breast cancer, prostate cancer, renal cell carcinoma, and lymphoma 6, 9, 10, 17, 18. The gene discussed is HAMP; the disease is hereditary clear cell renal cell carcinoma.